Metagenomi Therapeutics, Inc. MGX 深 沪
交易中 05-18 10:41:20 美东时间
1.28
-0.030
-2.29%
华盛通- 最 高1.3105
- 今 开1.31
- 成交量 9.08万股
- 最 低 1.28
- 昨 收 1.31
- 总市值 4818.80万
- 52周最高 3.95
- 市盈率 静 --
- 换手率 0.24%
- 52周最低 1.25
- 委 比 82.40%
- 总股本 3764.69万
- 历史最高 12.74
- 量 比 2.81
- 振 幅 2.33%
- 历史最低 1.23
- 每 手 1
- 风险率 0.43%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
Wells Fargo Maintains Overweight on Metagenomi Therapeutics, Lowers Price Target to $9
Wells Fargo analyst Yanan Zhu maintains Metagenomi Therapeutics (NASDAQ:MGX) with a Overweight and lowers the price target from $12 to $9.
05-12 21:27
Metagenomi Q1 EPS $(0.61) Misses $(0.55) Estimate, Sales $1.248M Miss $5.925M Estimate
Metagenomi (NASDAQ:MGX) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.55) by 10.91 percent. This is a 10.29 percent increase over losses of $(0.68) per share from the
05-12 04:23
Metagenomi Reports Study Showing CRISPR Editing Efficiency; Findings Support Development of Deliverable Gene Editing Systems
Metagenomi Therapeutics, Inc. (NASDAQ:MGX) (the "Company"), an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients, today announced a publication
04-16 19:04
Metagenomi Therapeutics Q4 Earnings Assessment
The earnings results for Metagenomi Therapeutics (NASDAQ:MGX) for Q4 were made ...
03-06 05:14
Metagenomi Changes Name To Metagenomi Therapeutics
New name reflects the Company's strategic evolution focused on later-stage preclinical assets leveraging its most advanced, signature gene-editing capabilitiesPre-IND meeting held in 4Q 2025 following MGX-001 preclinical
01-12 21:33
Metagenomi Prioritizes Hemophilia A Program, Lays Off 25% Workforce
Metagenomi reports curative-level FVIII activity for MGX-001 in primates and plans IND filing in 2026, extending cash runway into late 2027.
2025-11-13 01:09
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Leap Therapeutics (NASDAQ:LPTX) stock moved upwards by 176.6% to $1.21...
2025-11-13 01:05
Metagenomi shares are trading lower. The company reported Q3 financial results.
Metagenomi shares are trading lower. The company reported Q3 financial results.
2025-11-12 05:37
Metagenomi Q3 EPS $(0.55) Beats $(0.60) Estimate, Sales $8.659M Beat $7.400M Estimate
Metagenomi (NASDAQ:MGX) reported quarterly losses of $(0.55) per share which beat the analyst consensus estimate of $(0.60) by 7.87 percent. This is a 7.84 percent decrease over losses of $(0.51) per share from the same
2025-11-12 05:04
